41 related articles for article (PubMed ID: 19731280)
1. Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases.
Wang J; Liu Y; Guo Y; Liu C; Yang Y; Fan X; Yang H; Liu Y; Ma T
Biochem Pharmacol; 2024 Feb; 220():115973. PubMed ID: 38103797
[TBL] [Abstract][Full Text] [Related]
2. A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.
Li J; Kaoud TS; LeVieux J; Gilbreath B; Moharana S; Dalby KN; Kerwin SM
Chembiochem; 2013 Jan; 14(1):66-71. PubMed ID: 23225637
[TBL] [Abstract][Full Text] [Related]
3. A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38α Mitogen-Activated Protein Kinase Inhibitors.
Ansideri F; Andreev S; Kuhn A; Albrecht W; Laufer SA; Koch P
Molecules; 2018 Jan; 23(1):. PubMed ID: 29361698
[TBL] [Abstract][Full Text] [Related]
4. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
5. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
Wang Y; Wu M; Ai C; Wang Y
Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase.
Moallem SA; Hadizadeh F; Abdol Abadi F; Shahraki M; Shamsara J
Iran J Basic Med Sci; 2012 Jul; 15(4):945-50. PubMed ID: 23493837
[TBL] [Abstract][Full Text] [Related]
7. N-(4-Chloro-pyridin-2-yl)-N-meth-oxy-methyl-4-methyl-benzene-sulfonamide.
Bühler S; Schollmeyer D; Albrecht W; Laufer S
Acta Crystallogr Sect E Struct Rep Online; 2010 Nov; 66(Pt 12):o3321. PubMed ID: 21589598
[TBL] [Abstract][Full Text] [Related]
8. N-(4-Chloro-pyridin-2-yl)-N-(4-methyl-phenyl-sulfon-yl)acetamide.
Bühler S; Schollmeyer D; Albrecht W; Laufer S
Acta Crystallogr Sect E Struct Rep Online; 2010 Nov; 66(Pt 12):o3320. PubMed ID: 21589597
[TBL] [Abstract][Full Text] [Related]
9. 2-(4-Fluoro-phen-yl)-N-{4-[6-(4-fluoro-phen-yl)-2,3-dihydro-imidazo[2,1-b][1,3]thia-zol-5-yl]pyridin-2-yl}acetamide.
Selig R; Schollmeyer D; Albrecht W; Laufer S
Acta Crystallogr Sect E Struct Rep Online; 2010 Apr; 66(Pt 5):o1132. PubMed ID: 21579181
[TBL] [Abstract][Full Text] [Related]
10. (2Z)-2-Fluoro-N-{4-[5-(4-fluoro-phen-yl)-2-methyl-sulfanyl-1H-imidazol-4-yl]-2-pyrid-yl}-3-phenyl-acrylamide.
Selig R; Schollmeyer D; Stegmiller T; Albrecht W; Laufer S
Acta Crystallogr Sect E Struct Rep Online; 2009 Nov; 65(Pt 12):o3284. PubMed ID: 21578977
[TBL] [Abstract][Full Text] [Related]
11. N-{4-[4-(4-Fluoro-phen-yl)-1-(2-methoxy-ethyl)-2-methyl-sulfanyl-1H-imidazol-5-yl]-2-pyrid-yl}-2-methyl-3-phenyl-propionamide.
Ziegler K; Schollmeyer D; Laufer S
Acta Crystallogr Sect E Struct Rep Online; 2009 Nov; 65(Pt 12):o3128. PubMed ID: 21578851
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and SAR of phenylamino-substituted 5,11-dihydro-dibenzo[a,d]cyclohepten-10-ones and 11H-dibenzo[b,f]oxepin-10-ones as p38 MAP kinase inhibitors.
Dorn A; Schattel V; Laufer S
Bioorg Med Chem Lett; 2010 May; 20(10):3074-7. PubMed ID: 20418099
[TBL] [Abstract][Full Text] [Related]
13. Second-generation inhibitors demonstrate the involvement of p38 mitogen-activated protein kinase in post-transcriptional modulation of inflammatory mediator production in human and rodent airways.
Birrell MA; Wong S; McCluskie K; Catley MC; Hardaker EL; Haj-Yahia S; Belvisi MG
J Pharmacol Exp Ther; 2006 Mar; 316(3):1318-27. PubMed ID: 16368902
[TBL] [Abstract][Full Text] [Related]
14. Successful structure-based design of recent p38 MAP kinase inhibitors.
Karcher SC; Laufer SA
Curr Top Med Chem; 2009; 9(7):655-76. PubMed ID: 19689372
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors.
Bolós J
Mini Rev Med Chem; 2005 Sep; 5(9):857-68. PubMed ID: 16178727
[TBL] [Abstract][Full Text] [Related]
16. 2-Acylaminopyridin-4-ylimidazoles as p38 MAP kinase inhibitors: Design, synthesis, and biological and metabolic evaluations.
Ziegler K; Hauser DR; Unger A; Albrecht W; Laufer SA
ChemMedChem; 2009 Nov; 4(11):1939-48. PubMed ID: 19731280
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.
Laufer SA; Hauser DR; Domeyer DM; Kinkel K; Liedtke AJ
J Med Chem; 2008 Jul; 51(14):4122-49. PubMed ID: 18578517
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
